More News

14 Sep 2020 Gilead Sciences to Acquire Immunomedics
12 Sep 2020 Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia
10 Sep 2020 Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program
09 Sep 2020 Bayer collaborates with Recursion to strengthen digital drug discovery and advance new therapies for fibrotic diseases
08 Sep 2020 Exelixis and Catalent Enter into Collaboration, License, and Exclusive Option Agreement to Develop Antibody-Drug Conjugates Leveraging SMARTag® Bioconjugation Technology
08 Sep 2020 Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
07 Sep 2020 Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome
04 Sep 2020 Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia
02 Sep 2020 BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease
02 Sep 2020 Orca Bio and Lyell Immunopharma Announce Research Partnership
02 Sep 2020 Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient and In Vivo Production of Antibody Therapeutics in Patients
01 Sep 2020 Boston Pharmaceuticals Licenses NASH Development Candidate from Novartis
01 Sep 2020 Elektrofi and LEO Pharma Enter Licensing Agreement for Development of High-Concentration, Low-Volume Formulations of Investigational Monoclonal Antibodies
01 Sep 2020 Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling pathways of GPCRs across multiple diseases
01 Sep 2020 SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
31 Aug 2020 Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science
31 Aug 2020 Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
26 Aug 2020 ACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program to Portfolio
25 Aug 2020 AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases
25 Aug 2020 Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases
25 Aug 2020 Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
24 Aug 2020 NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and Related Therapeutics
21 Aug 2020 Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer Therapeutics
19 Aug 2020 Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases
18 Aug 2020 LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up